Site is Being Upgraded

Alternative sweetener-based Lifespan extension therapy: Fructooligosaccharide, an alternative sweetener 30-50% as sweet as sugar,   increases life span via up-regulation of its target gene BubR1, 2/April/2017, 12.05 pm

A sweet way to say no to Diabetes Mellitus: D-Mannose, a C-2 epimer of glucose, augments the expression of FGF19 and FGF1,  attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIDM via up regulation of its target gene, 2/April/2018, 11.30 am
April 2, 2018
A sweet way to decrease blood pressure/sugar and extend lifespan: Sugar-based Lifespan extension therapy:  D-Allose, a C-3 epimer of glucose,  prolongs mammalian life span, via down regulation of angiotensin II type I receptor (AT1R), 4/April/2018, 12.19 pm
April 2, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Alternative sweetener-based Lifespan extension therapy: Fructooligosaccharide, an alternative sweetener 30-50% as sweet as sugar,   increases life span via up-regulation of its target gene BubR1


What is known? 

Fructooligosaccharide has been shown to shown to function as anti-hyperglycemic agent. However, the exact mechanism of action is far from clear.


From research findings to therapeutic Opportunity: 

Fructooligosaccharide (oligofructose or oligofructan) can be isolated from blue Agave, bananas, onions, shallots, chicory root, garlic, asparagus, jícama, and leeks.  It is 30-50% as sweet as sugar.

This study suggests, for the first time, that Fructooligosaccharideby increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (Fig. 1).

[easy_payment currency=”USD”]

Figure 1. Fructooligosaccharide may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Figure 2. Fructooligosaccharide as a longevity-promoting agent.

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median life span. Thus, pharmacological formulations encompassing “Fructooligosaccharide  or its analogues, either alone or in combination with other drugs,may be used to extend the lifespan of an individual (fig. 1).


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How Fructooligosaccharide  increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Alternative sweetener-based Lifespan extension therapy: Fructooligosaccharide, an alternative sweetener 30-50% as sweet as sugar,   increases life span via up-regulation of its target gene BubR1, 2/April/2017, 12.05 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.